Yili Chuanning Biotechnology News and Activities

Yili Chuanning Biotechnology is owned by Sichuan Colon Pharmaceutical.

Sichuan Colon Pharmaceutical is one of the...

• CSI 300;
• TOB Iconic 10,000.

Sichuan Colon Pharmaceutical is a company listed under the stock ticker 002422 (CN).

They are in:

• Pharmaceuticals50%
• Biotechnology50%

View the org chart displaying its 8 main executives

Most searched biographies at Yili Chuanning Biotechnology

• Xuheng Deng, Chief Executive Officer
• Yali Cao, Independent Director
• Hong Duan, Director

Create your alert
to follow the executive moves at Yili Chuanning Biotechnology.

Sichuan Colon Pharmaceutical has 2,405 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Carl Gordon - Director at Odyssey Therapeutics

Learn more about the Biotechnology industry

Press releases by Yili Chuanning Biotechnology

• 伊犁川宁生物技术股份有限公司2025年生物基可降解材料生产制造技改工程项目环评批复临时环境信息依法披露报告-环保要闻-川宁生物
• 伊犁川宁生物技术股份有限公司2025年排污许可证变更临时环境信息依法披露报告-环保要闻-川宁生物
• 环保要闻-川宁生物

Social media about Yili Chuanning Biotechnology

• Yili Chuanning Biotechnology on Wikipedia, Google News & Yahoo Finance
• Yili Chuanning Biotechnology on LinkedIn, X (Twitter) & YouTube